1.
ERJ Open Res
; 7(4)2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34881326
RESUMO
Within 1 year, 15% of Canadian patients with severe asthma discontinue benralizumab. The reasons for discontinuation are not yet characterised. https://bit.ly/3kaRDlp.